Researchers in Austria showed duplex ultrasound measurements of the carotid artery could demonstrate the progression of stenosis and predict which patients would suffer serious cardiovascular complications.
Researchers in Austria showed duplex ultrasound measurements of the carotid artery could demonstrate the progression of stenosis and predict which patients would suffer serious cardiovascular complications.
Dr. Schila Sabeti and colleagues at Medical University Vienna and Wilhelminenhospital in Vienna published their findings Sept. 20 online before print in the journal Stroke.
Of 1268 consecutive patients with no signs of carotid disease, 1065 were included in this study. Their carotid arteries were prospectively studied with duplex ultrasound exams to establish a baseline. After a median of 7.5 months - ranging from six to nine months - the tests were repeated.
The new measurements were compared with the baseline for each patient, using Doppler velocity criteria to identify those with progressive stenosis. They were then followed clinically for a median of 3.2 years to track major adverse cardiovascular events. For the purposes of this study, these included myocardial infarction, percutaneous coronary or peripheral interventions, coronary or vascular surgery, amputation, stroke, and death for any reason.
Ultrasound detected progressive carotid stenosis in 93 patients, or 9% of the total. By the end of the study, 495 major adverse cardiovascular events had been recorded in 421 patients, or 40% of the total.
Patients with progressive carotid stenosis were at significantly higher risk for major cardiovascular events than those with nonprogressive disease. They are twice as likely to experience any of the major cardiovascular events. The hazard ratio was 2.01 with a confidence interval of 95% for all major events combined and especially high specifically for myocardial infarction (2.38) and any peripheral vascular event (2.42). The hazard ratio for any coronary event was 1.59, for stroke 2.00, and for cardiovascular death 1.75 - all with a confidence interval of 95%.
The researchers concluded that duplex ultrasound sonography of the carotid artery can be used to predict midterm adverse events of atherosclerosis with just two measurements six to nine months apart.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Month, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.